The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Aminoferrocene-Based Prodrugs Activated by Reactive Oxygen Species
Abstract
Cancer cells generally generate higher amounts of reactive oxygen species than normal cells. On the basis of this difference, prodrugs have been developed (e.g., hydroxyferrocifen), which remain inactive in normal cells, but become activated in cancer cells. In this work we describe novel aminoferrocene-based prodrugs, which, in contrast to hydroxyferrocifen, after activation form not only quinone methides (QMs), but also catalysts (iron or ferrocenium ions). The released products act in a concerted fashion. In particular, QMs alkylate glutathione, thereby inhibiting the antioxidative system of the cell, whereas the iron species induce catalytic generation of hydroxyl radicals. Since the catalysts are formed as products of the activation reaction, it proceeds autocatalytically. The most potent prodrug described here is toxic toward cancer cells (human promyelocytic leukemia (HL-60), IC(50) = 9 μM, and human glioblastoma-astrocytoma (U373), IC(50) = 25 μM), but not toxic (up to 100 μM) toward representative nonmalignant cells (fibroblasts).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Trachootham, D., Alexandre, J., & Huang, P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2803 · Cited by 5,452
Production of large amounts of hydrogen peroxide by human tumor cells.
Szatrowski, T. P., & Nathan, C. (1991) · PubMed · Cited by 2,526
Oxidant signals and oxidative stress
Finkel, T. (2003) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(03)00002-4 · Cited by 1,393
Direct Cellular Responses to Platinum-Induced DNA Damage
Jung, Y., & Lippard, S. J. (2007) · Chemical Reviews · doi:10.1021/cr068207j · Cited by 1,391
Bioorganometallic Chemistry of Ferrocene
van Staveren, D. R., & Metzler-Nolte, N. (2004) · Chemical Reviews · doi:10.1021/cr0101510 · Cited by 1,319
Oxidative stress and cancer: Have we moved forward?
Halliwell, B. (2007) · Biochemical Journal · doi:10.1042/bj20061131 · Cited by 1,302
Reactive oxygen species in cancer cells: Live by the sword, die by the sword
Schumacker, P. T. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.015 · Cited by 1,242
Trachootham, D., Zhou, Y., Zhang, H., Demizu, Y., Chen, Z., Pelicano, H., Chiao, P. J., Achanta, G., Arlinghaus, R. B., Liu, J., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.009 · Cited by 1,080
Beckman, K. B., & Ames, B. N. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.32.19633 · Cited by 951
Goldstein, S., Meyerstein, D., & Czapski, G. (1993) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(93)90043-t · Cited by 674
Nucleoside analogues and nucleobases in cancer treatment
Galmarini, C. M., Mackey, J. R., & Dumontet, C. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00788-x · Cited by 606
Non-platinum group metal antitumor agents. History, current status, and perspectives
Koepf-Maier, P., & Koepf, H. (1987) · Chemical Reviews · doi:10.1021/cr00081a012 · Cited by 509
Estimation of H2O2 gradients across biomembranes
Antunes, F., & Cadenas, E. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01638-0 · Cited by 498
Supramolecular Photonic Therapeutic Agents
McDonnell, S. O., Hall, M. J., Allen, L. T., Byrne, A., Gallagher, W. M., & O'Shea, D. F. (2005) · Journal of the American Chemical Society · doi:10.1021/ja0553497 · Cited by 346
Catalytic organometallic anticancer complexes
Dougan, S. J., Habtemariam, A., McHale, S. E., Parsons, S., & Sadler, P. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800076105 · Cited by 303
Spontaneous cancer and its possible relationship to oxygen metabolism.
Totter, J. R. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.4.1763 · Cited by 296
Ferricenium complexes: A new type of water-soluble antitumor agent
K�pf-Maier, P., K�pf, H., & Neuse, E. W. (1984) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf00390468 · Cited by 248
The emerging role of reactive oxygen species in cancer therapy
Renschler, M. F. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.02.031 · Cited by 237
Oxidative stress and apoptosis: a new treatment paradigm in cancer
Engel, R. (2006) · Frontiers in Bioscience · doi:10.2741/1798 · Cited by 202
An assessment of proposed mechanisms for sensing hydrogen peroxide in mammalian systems
Stone, J. R. (2004) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.12.029 · Cited by 192
Hulsman, N., Medema, J. P., Bos, C. L., Jongejan, A., Leurs, R., Smit, M. J., de Esch, I. J. P., Richel, D. J., & Wijtmans, M. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061371e · Cited by 157
A Pro-Chelator Triggered by Hydrogen Peroxide Inhibits Iron-Promoted Hydroxyl Radical Formation
Charkoudian, L. K., Pham, D. M., & Franz, K. J. (2006) · Journal of the American Chemical Society · doi:10.1021/ja064806w · Cited by 150
Hydrogen Peroxide Activated Matrix Metalloproteinase Inhibitors: A Prodrug Approach
Jourden, J. L. M., & Cohen, S. M. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201003819 · Cited by 131
Combating Alzheimer's Disease With Multifunctional Molecules Designed for Metal Passivation
Schugar, H. J., Green, D. E., Bowen, M. L., Scott, L. E., Storr, T., Böhmerle, K., Thomas, F. C., Allen, D. D., Lockman, P. R., Merkel, M., et al. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200603866 · Cited by 112
Arsenic trioxide: Mechanisms of action
Davison, K. L., Mann, K. K., & Miller, W. H. (2002) · Seminars in Hematology · doi:10.1053/shem.2002.33610 · Cited by 103
Wlassoff, W. A., Albright, C. D., Ms, S., Ivanova, A., Appelbaum, J. G., & Salganik, R. I. (2007) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.59.11.0013 · Cited by 98
Folk, D. S., & Franz, K. J. (2010) · Journal of the American Chemical Society · doi:10.1021/ja100943r · Cited by 85
The mechanism of action of nitric oxide-donating aspirin
Kashfi, K., & Rigas, B. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.05.038 · Cited by 67
Resistance of human tumor cells in vitro to oxidative cytolysis.
O’Donnell-Tormey, J., DeBoer, C. J., & Nathan, C. F. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111981 · Cited by 61
Wei, Y., & Guo, M. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200604859 · Cited by 50
Pigeon, P., Top, S., Vessières, A., Huché, M., Görmen, M., Arbi, M. E., Plamont, M., McGlinchey, M. J., & Jaouen, G. (2011) · New Journal of Chemistry · doi:10.1039/c1nj20192a · Cited by 45
Wei, Y., & Guo, M. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200790184 · Cited by 43
Dorr, R. T., Liddil, J. D., & Soble, M. J. (1986) · Investigational New Drugs · doi:10.1007/bf00173503 · Cited by 32
An autocatalytic chromogenic and fluorogenic photochemical reaction controlled by nucleic acids
Dutta, S., & Mokhir, A. A. (2010) · Chemical Communications · doi:10.1039/c0cc02508a · Cited by 26
Self-citation
Cited by
Reactive oxygen species and cancer paradox: To promote or to suppress?
Galadari, S., Rahman, A., Pallichankandy, S., & Thayyullathil, F. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.01.004 · Cited by 893
Engineering nanomedicine for glutathione depletion-augmented cancer therapy
Xiong, Y., Xiao, C., Li, Z., & Yang, X. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00718h · Cited by 692
Reactive‐Oxygen‐Species‐Responsive Drug Delivery Systems: Promises and Challenges
Saravanakumar, G., Kim, J., & Kim, W. J. (2017) · Advanced Science · doi:10.1002/advs.201600124 · Cited by 675
Stimuli-Responsive Therapeutic Metallodrugs
Wang, X., Wang, X., Jin, S., Muhammad, N., & Guo, Z. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00209 · Cited by 649
Fluorogenic probes for disease-relevant enzymes
Zhang, J., Chai, X., He, X.-P., Kim, H.-J., Yoon, J., & Tian, H. (2019) · Chemical Society Reviews · doi:10.1039/c7cs00907k · Cited by 606
Metadata
- Authors
- Hagen, H., Marzenell, P., Jentzsch, E., Wenz, F., Veldwijk, M. R., & Mokhir, A.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2012-01-11
- Volume
- 55
- Issue
- 2
- Pages
- 924-934
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2332035638
- Cited by
- 260
- References
- 34
- FWCI
- 3.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.